Clinical trial
Pharmacogenomics of Paclitaxel in Ovarian Cancer
NCT00415181 · University of Southern Denmark, Other · Completed
Key facts
| NCT number | NCT00415181 |
|---|---|
| Title | Pharmacogenomics of Paclitaxel in Ovarian Cancer |
| Official title | The Pharmacogenomics of Paclitaxel in Patients With Ovarian Cancer: Predictors of Toxicity and Response |
| Lead sponsor | University of Southern Denmark, Other |
| Collaborators | Danish Clinical Intervention Research Academy Ministry of the Interior and Health, Denmark |
| Status | Completed |
| Study type | Observational |
| Conditions | Ovarian Neoplasms, Fallopian Tube Neoplasms |
| Enrollment | 93 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2013 |
| First posted | Dec 22, 2006 |
| Last update posted | Jan 13, 2015 |
| Countries | Denmark, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: